Discontinued — last reported Q3 '22
Honeywell International Acquisitions decreased by 54.5% to $5.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $5.00M to $5.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 13.5% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $24.00M | $7.00M | $0.00 | $176.00M | $2.00M | $0.00 | $0.00 | $0.00 | $661.00M | $55.00M | $2.00M | $0.00 | $4.91B | $2.13B | $1.83B | $5.00M | $2.16B | $37.00M | $11.00M | $5.00M |
| QoQ Change | — | -70.8% | -100.0% | — | -98.9% | -100.0% | — | — | — | -91.7% | -96.4% | -100.0% | — | -56.6% | -14.1% | -99.7% | >999% | -98.3% | -70.3% | -54.5% |
| YoY Change | — | — | — | — | -91.7% | -100.0% | — | -100.0% | >999% | — | — | — | +643.3% | >999% | >999% | — | -56.1% | -98.3% | -99.4% | +0.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.